Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gicobi JK"'
Autor:
Gicobi JK; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Mao Z; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., DeFranco G; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Hirdler JB; Department of Urology, Mayo Clinic, Rochester, MN, USA., Li Y; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA., Vianzon VV; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Dellacecca ER; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Hsu MA; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Barham W; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Yan Y; Division of Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Wu X; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Hitosugi T; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Owen D; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Grams MP; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Orme JJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Lucien F; Department of Urology, Mayo Clinic, Rochester, MN, USA., Zeng H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Department of Rheumatology, Mayo Clinic, Rochester, MN, USA., Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Dong H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Science advances [Sci Adv] 2023 Nov 17; Vol. 9 (46), pp. eadi2414. Date of Electronic Publication: 2023 Nov 15.
Autor:
An Z; Department of Immunology, Mayo Clinic, Rochester, MN.; Department of Urology, Mayo Clinic, Rochester, MN., Hsu MA; Department of Immunology, Mayo Clinic, Rochester, MN., Gicobi JK; Department of Immunology, Mayo Clinic, Rochester, MN., Xu T; Department of Immunology, Mayo Clinic, Rochester, MN., Harrington SM; Department of Urology, Mayo Clinic, Rochester, MN., Zhang H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Pavelko KD; Immune Monitoring Core, Mayo Clinic, Rochester, MN., Hirdler JB; Department of Immunology, Mayo Clinic, Rochester, MN., Lohse CM; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Nabavizadeh R; Department of Urology, Mayo Clinic, Rochester, MN., Pessoa RR; Department of Urology, Mayo Clinic, Rochester, MN., Sharma V; Department of Urology, Mayo Clinic, Rochester, MN., Thompson RH; Department of Urology, Mayo Clinic, Rochester, MN., Leibovich BC; Department of Urology, Mayo Clinic, Rochester, MN., Dong H; Department of Immunology, Mayo Clinic, Rochester, MN.; Department of Urology, Mayo Clinic, Rochester, MN., Lucien F; Department of Immunology, Mayo Clinic, Rochester, MN.; Department of Urology, Mayo Clinic, Rochester, MN.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2023 Jun 15; Vol. 210 (12), pp. 2029-2037.
Autor:
Gicobi JK; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA., Dellacecca ER; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA., Dong H; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA. dong.haidong@mayo.edu.
Publikováno v:
International journal of hematology [Int J Hematol] 2023 May; Vol. 117 (5), pp. 634-639. Date of Electronic Publication: 2022 Jul 21.
Autor:
Barham W; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN., Hsu M; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN., Liu X; Department of Urology, Mayo Clinic, Rochester, MN., Harrington SM; Department of Urology, Mayo Clinic, Rochester, MN., Hirdler JB; Department of Urology, Mayo Clinic, Rochester, MN., Gicobi JK; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN., Zhu X; Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN; and., Zeng H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN.; Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN; and., Pavelko KD; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN., Yan Y; Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN., Mansfield AS; Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN., Dong H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN.; Department of Urology, Mayo Clinic, Rochester, MN.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2023 Jan 01; Vol. 7 (1), pp. 125-139.
Autor:
Wen T; Department of Urology, Mayo Clinic, Rochester, Minnesota., Barham W; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Li Y; Division of Computational Biology, Mayo Clinic, Rochester, Minnesota., Zhang H; Department of Urology, Mayo Clinic, Rochester, Minnesota., Gicobi JK; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Hirdler JB; Department of Urology, Mayo Clinic, Rochester, Minnesota., Liu X; Department of Urology, Mayo Clinic, Rochester, Minnesota., Ham H; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Peterson Martinez KE; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Lucien F; Department of Urology, Mayo Clinic, Rochester, Minnesota., Lavoie RR; Department of Urology, Mayo Clinic, Rochester, Minnesota., Li H; Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Correia C; Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Monie DD; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., An Z; Department of Urology, Mayo Clinic, Rochester, Minnesota., Harrington SM; Department of Urology, Mayo Clinic, Rochester, Minnesota., Wu X; Division of Hematology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Guo R; Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Dronca RS; Division of Medical Oncology, Mayo Clinic, Jacksonville, Florida., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Yan Y; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Markovic SN; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Sun J; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota., Qin H; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida., Liu MC; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Vasmatzis G; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Billadeau DD; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota., Dong H; Department of Urology, Mayo Clinic, Rochester, Minnesota. dong.haidong@mayo.edu.; Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Feb; Vol. 10 (2), pp. 162-181. Date of Electronic Publication: 2021 Dec 15.
Autor:
Driouk L; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States., Gicobi JK; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States., Kamihara Y; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States., Rutherford K; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States., Dranoff G; Novartis Institutes of Biomedical Research, Cambridge, MA, United States., Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Baumeister SHC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Dec 15; Vol. 11, pp. 580328. Date of Electronic Publication: 2020 Dec 15 (Print Publication: 2020).
Autor:
Gicobi JK; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA., Barham W; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA., Dong H; Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA. dong.haidong@mayo.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Nov; Vol. 69 (11), pp. 2165-2167.
Autor:
Barham W; Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, USA.; Department of Immunology, Mayo Clinic, Rochester, MN, USA., Gicobi JK; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Department of Immunology, Mayo Clinic, Rochester, MN, USA., Yan Y; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Dronca RS; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA., Dong H; Department of Immunology, Mayo Clinic, Rochester, MN, USA.; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Genes & diseases [Genes Dis] 2019 Jul 10; Vol. 6 (3), pp. 224-231. Date of Electronic Publication: 2019 Jul 10 (Print Publication: 2019).
Autor:
Baumeister SH; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology-Oncology Boston Children's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Murad J; Celdara Medical, LLC, Lebanon, New Hampshire., Werner L; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Daley H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Trebeden-Negre H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Gicobi JK; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Schmucker A; Celdara Medical, LLC, Lebanon, New Hampshire., Reder J; Celdara Medical, LLC, Lebanon, New Hampshire., Sentman CL; Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Gilham DE; Celyad, SA, Mont-Saint-Guibert, Belgium., Lehmann FF; Celyad, SA, Mont-Saint-Guibert, Belgium., Galinsky I; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., DiPietro H; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Cummings K; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Munshi NC; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Stone RM; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Neuberg DS; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts., Soiffer R; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Dranoff G; Novartis BioMedical Institutes, Cambridge, Massachusetts., Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Nikiforow S; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts. sarah_nikiforow@dfci.harvard.edu.; Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Jan; Vol. 7 (1), pp. 100-112. Date of Electronic Publication: 2018 Nov 05.